Skip to main content
. 2020 Oct 22;15(1):80–90. doi: 10.1002/1878-0261.12817

Fig. 2.

Fig. 2

Variant allele fraction (VAF) of BRCA1/2 tumor variants. Comparison of VAF of PV versus VUS identified on tumor testing. A higher proportion of PVs were present at a VAF > 40% as compared to VUS (76% vs 56%).